Сhanges of cortisol level in patients with COVID-19 and cognitive disorders
DOI:
https://doi.org/10.12775/JEHS.2023.13.05.027Keywords
pathogenesis, cognitive dysfunction, COVID-19, cortisol, markerAbstract
The article is presents results of the changes pf cortisol level in patients with COVID-19 and cognitive disorders. It was established increase the main marker of stress – cortisol relative to the physiological norm in all age groups of patients who suffered from COVID-19 and were hospitalized. In the age group 40-50 years, the cortisol level increased on the first day in men on 1.4 times (p˂0.05) and in women on 1.2 times (p˂0.05) compared to the physiological norm. Therefore, cortisol can be considered a diagnostically significant trigger for the development of cognitive disorders, which will subsequently lead to drastic changes in the central nervous system.
References
1. Assesment of DHEAS, cortisol. and DHEAS/cortisol ration in patients with COVID-19: a pilot study / S. Tomo, M. Banerjee, S. Karli et al. Hormones. 2022. Vol. 1. P. 4–8.
2. Association between high serum total cortisol concentrations and mortality from COVID-19 / T. Tan, B. Khoo, E. G. Mills et al. The Lancet. 2020. Vol. 8 (8). P. 659–660.
3. Choy K. W. Cortisol concentrations and mortality from COVID-19. The Lancet. 2020. Vol. 8 (10). P. 808.
4. Dziurkowska E., Wesolowski M. Cortisol as a biomarker of mental disorder severity. Journal of clinical medicine. 2021. Vol. 21 (10). P. 5204.
5. Evaluation of stress, burnout and hair cortisol levels in health workers at a University Hospital during COVID-19 / C. Ibar, F. Fortuna, D. Gonzalez et al. Psychoneuroendocrinology. 2021. Vol. 128. e105213.
6. Frenkel S. M., Vlasenko O. O., Savytskyi I. V., Savytskyi V. I., Badiuk N. S. Features of students mental health indicators during the academic year under pandemic conditions of COVID-19 / PharmacologyOnLine; Archives - 2021 - vol. 2 – 776-780.
7. Henley D., Lightman S., Carrell R. Cortisol and CBG – getting cortisol to the right place at the right time. Pharmacology and Therapeutics. 2016. Vol. 166. P. 128–135.
8. Inflammatory markers and cortisol parameters across depressive subtypes in an older cohort / E. M. Veltman, F. Lamers, H. C. Comijs et al. Journal of Affective Disorders. 2018. Vol. 234. P. 54–58.
9. Linking emotional control and stress reactivity: anterior prefrontal cortex activation during emotion control predicts cortisol response after stress induction / R. Kaldewaij, S. Koch, W. Zhang et al. Biological Psychiatry. 2018. Vol. 83, No. 9. P. 240–241.
10. Pal R., Banerjee M., Bhadada S. K. Cortisol concentrations and mortality from COVID-19. The Lancet. 2022. Vol. 10 (8). P. 809.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 V. Sarakhan
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 21
Number of citations: 0
